Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era

    Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era

    FromNeuro-Oncology: The Podcast

    Start listeningView podcast show

    Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era

    FromNeuro-Oncology: The Podcast

    ratings:
    Length:
    13 minutes
    Released:
    Mar 3, 2023
    Format:
    Podcast episode

    Description

    Dr. Iyad Alnahhas interviews Dr. Max Kros about his and his team's recent manuscript entitled: "Mitotic count is prognostic in IDH-mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trials 26053 and EORTC 22033-26033", published online in Neuro-Oncology in December 2022.   Read Paper
    Released:
    Mar 3, 2023
    Format:
    Podcast episode

    Titles in the series (79)

    Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.